New York, NY -- (SBWIRE) -- 12/06/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Federal National Mortgage Assctn Fnni Me (OTCBB:FNMA), Frontline Ltd (NYSE:FRO), Ariad Pharmaceuticals, Inc (NASDAQ:ARIA), eBay Inc (NASDAQ:EBAY)
Federal National Mortgage Assctn Fnni Me (OTCBB:FNMA) showed a volume of 5.21 million shares by the end of last trade whereas the average volume of the stock remained 37.96 million shares. The stock opened the session at $2.73 but then moved to $2.73. At that price, the stock showed a negative performance of -1.09%. Federal National Mortgage Association Fannie Mae is a government-sponsored enterprise (GSE) chartered by the United States Congress to support liquidity and stability in the secondary mortgage market, where mortgage-related assets are purchased and sold. The Company’s activities include providing market liquidity by securitizing mortgage loans originated by lenders in the primary mortgage market into Fannie Mae mortgage-backed securities (Fannie Mae MBS), and purchasing mortgage loans and mortgage.
Will FNMA Get Buyers Even After The Recent Rally? Find Out Here
Frontline Ltd (NYSE:FRO) opened the session at $3.67 and closed the session at $3.56. The stock showed a negative performance of -5.82% in previous trading session. Traded with volume of 2.31million shares in the prior session and the average volume of the stock remained 1.46 million shares. Frontline Ltd. is a Bermuda-based shipping company engaged primarily in the ownership and operation of oil tanker. The Company operates oil tankers of two sizes: Very Large Crude Carriers (VLCCs), which are between 200,000 and 320,000 deadweight tonnages (dwt), and Suezmax tankers, which are vessels between 120,000 and 170,000 dwt. The Company operates through subsidiaries and partnerships located in the Bahamas,
Has FRO Found The Bottom And Ready To Gain Momentum? Find Out Here
Ariad Pharmaceuticals, Inc (NASDAQ:ARIA) opened the session at $4.85 and closed the session at $4.57. The stock showed a negative performance of -5.58% in previous trading session. Traded with volume of 14.15 million shares in the prior session and the average volume of the stock remained 22.81 million shares. The beta of the stock remained 0.81. ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients. ARIAD’s first medicine, Iclusig, is approved in the United States for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI)
Why Should Investors Buy ARIA After the Recent Fall? Just Go Here and Find Out
eBay Inc (NASDAQ:EBAY) the stock advanced 0.63% and finished the session at $51.41. Traded with volume of 9.93 million shares in the prior session and the average volume of the stock remained 14.00 million shares. The beta of the stock remained 1.25. eBay Inc. is a global technology company that enables commerce through three reportable segments: Marketplaces, Payments, and GSI. The Company by providing online platforms, tools and services to help individuals and small, medium and merchants around the globe engage in online and mobile commerce and payments, the Company can facilitate transactions. The company also generates revenue through marketing services,
Will EBAY Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)